# Vasoactive Peptides in Portal Pressure

> **NCT00163982** · NA · UNKNOWN · sponsor: **Bayside Health**

## Conditions studied

- Portal Hypertension

## Interventions

- **DRUG:** Norfloxacin

## Key facts

- **NCT ID:** NCT00163982
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163982, "Vasoactive Peptides in Portal Pressure". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00163982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*